Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Astrazeneca Plc (AZN.LN)

Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Astrazeneca Plc 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA GBR

https://www.astrazeneca.com P: 203-749-5000 F: 122-335-2858

Description:

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

Key Statistics

Overview:

Market Capitalization, $K 155,402,462
Shares Outstanding, K 1,550,304
Annual Sales, $ 45,811 M
Annual Net Income, $ 5,955 M
Last Quarter Sales, $ 13,565 M
Last Quarter Net Income, $ 1,429 M
% of Insider Shareholders 0.14%
% of Institutional Shareholders 67.75%

Growth:

1-Year Return -1.28%
3-Year Return 18.52%
5-Year Return 33.67%
5-Year Revenue Growth 15.71%
5-Year Earnings Growth 17.52%
5-Year Dividend Growth 0.92%

Per-Share Information:

Most Recent Earnings 1.24 on 07/25/24
Next Earnings Date N/A
Earnings Per Share ttm 4.12
EPS Growth vs. Prev Qtr -11.43%
EPS Growth vs. Prev Year 4.55%
Annual Dividend Rate, $ 2.89
Annual Dividend Yield 2.33%
Most Recent Dividend 0.776 on 08/08/24
Next Ex-Dividends Date 08/08/24
Dividend Payable Date 09/09/24
Dividend Payout Ratio 72.14%

AZN.LN Ratios

Ratio
Price/Earnings ttm 30.62
Price/Earnings forward 13.57
Return-on-Equity % 16.67%
Return-on-Assets % 6.46%
Profit Margin % 13.00%
Debt/Equity 0.59
Price/Sales 3.88
Price/Book 4.84
Book Value/Share 20.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar